NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Ruby Bio

Ruby Bio

Private
Oakland, CaliforniaFrontier & Industrial Techhttps://rubybio.com/

Last Round

Seed

Jun 9, 2025

Total Funding Raised

$13.12M

Company Overview

Ruby Bio is a biotechnology company that develops a biomanufacturing platform using yeast-based fermentation to produce bio-based chemicals and ingredients.

Sector

Frontier & Industrial Tech

Verticals

Biotechnology, Sustainable Materials, Clean Manufacturing, Circular Economy

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

precision fermentationsynthetic biologybiosurfactantsbiomanufacturingpalm oil alternativessustainable chemicalsfood emulsifierspetrochemical alternativesclean label ingredientsyeast fermentationspecialty chemicalsoleochemicalsstrain engineeringwaste valorizationbiomonomers

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ruby Bio Comparables

Compare Ruby Bio with similar companies based on industry and business-model similarity.

Ruby Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AmphiStar
84%
C16 Biosciences
82%
Dispersa
82%

Ruby Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 9, 2025
SeedAug 31, 2023

Key People

Founding team and executive leadership

Charlie Silver

Founding CEO

Founding Team

Pavan Kambam

Chief Technology Officer

Executive Team

Ruby Bio Investors

Notable investors and investment history

Ruby Bio investors
InvestorRounds
Kicker VenturesSeed
F4 FundSeed
Fusion FundSeed
IBX Investment PartnersSeed
Alumni VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 26, 2025

    Grew 27% QoQ from 11 to 14 employees.

  • Jun 9, 2025

    Raised $8M from Bascom Ventures, IBX, and Kicker Ventures.

Ruby Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ruby Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ruby Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersOakland, California
Employee Range14
Year Founded2022
Last FundingJun 9, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.